Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,727 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A).
Katayama H, Mizusawa J, Fukuda H, Nakamura S, Nakamura K, Saijo N, Yokoyama A, Ohe Y, Shinkai T, Nakagawa K, Abe T, Mitsuoka S, Okamoto H, Yamamoto N, Yoshioka H, Ando M, Tamura T, Takeda K. Katayama H, et al. Among authors: tamura t. Jpn J Clin Oncol. 2021 Apr 30;51(5):685-692. doi: 10.1093/jjco/hyaa257. Jpn J Clin Oncol. 2021. PMID: 33479759 Clinical Trial.
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.
Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T, Fukuda H, Saijo N. Takada M, et al. Among authors: tamura t. J Clin Oncol. 2002 Jul 15;20(14):3054-60. doi: 10.1200/JCO.2002.12.071. J Clin Oncol. 2002. PMID: 12118018 Clinical Trial.
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].
Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S, Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S, Macleod A, Feyereislova A, Dong RP, Baselga J. Fukuoka M, et al. Among authors: tamura t. J Clin Oncol. 2003 Jun 15;21(12):2237-46. doi: 10.1200/JCO.2003.10.038. Epub 2003 May 14. J Clin Oncol. 2003. PMID: 12748244 Clinical Trial.
Strategy for the development of novel anticancer drugs.
Saijo N, Tamura T, Nishio K. Saijo N, et al. Among authors: tamura t. Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S97-101. doi: 10.1007/s00280-003-0596-x. Epub 2003 Jun 18. Cancer Chemother Pharmacol. 2003. PMID: 12856152 Review.
Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: a retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A).
Ohe Y, Ishizuka N, Tamura T, Sekine I, Nishiwaki Y, Saijo N; Japan Clinical Oncology Group. Ohe Y, et al. Among authors: tamura t. Cancer Sci. 2003 Aug;94(8):729-34. doi: 10.1111/j.1349-7006.2003.tb01510.x. Cancer Sci. 2003. PMID: 12901800 Free PMC article.
4,727 results